The Future of Biological Therapies in COPD.
Sign Up to like & getrecommendations! Published in 2018 at "Archivos de bronconeumologia"
DOI: 10.1016/j.arbres.2017.11.004
Abstract: In recent years new treatments that go further than conventional therapeutical approaches (i.e. bronchodilators and classical antoinflammatory drugs) have been developed for COPD. Bronchodilators are used to try to increase the size of the airway… read more here.
Keywords: response; copd; therapies copd; biological therapies ... See more keywords
Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey.
Sign Up to like & getrecommendations! Published in 2018 at "Archivos de bronconeumologia"
DOI: 10.1016/j.arbres.2018.04.004
Abstract: INTRODUCTION Treatment with biological therapies increases the incidence of tuberculous disease. The introduction of systematic screening for latent tuberculosis infection in patients who are to receive these therapies has reduced this risk. In 2016, the… read more here.
Keywords: tuberculosis; screening latent; latent tuberculosis; tuberculosis infection ... See more keywords
Research on biological therapies in systemic lupus erythematosus.
Sign Up to like & getrecommendations! Published in 2017 at "Medicina clinica"
DOI: 10.1016/j.medcli.2016.10.025
Abstract: El tratamiento del lupus eritematoso sistémico (LES) se ha asado a lo largo de los años en la experiencia clínica y en la videncia emanada de estudios observacionales sobre la eficacia e los inmunodepresores clásicos1.… read more here.
Keywords: ensayos nicos; los ensayos; los; research biological ... See more keywords
Advances in biological therapies for dyslipidemias and atherosclerosis.
Sign Up to like & getrecommendations! Published in 2020 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2020.154461
Abstract: Atherosclerosis is a multifactorial disease influenced by genetics, lifestyle and environmental factors. Despite therapeutic advances that reduce the risk of cardiovascular events, atherosclerosis-related diseases remain the leading cause of mortality worldwide. Precise targeting of genes… read more here.
Keywords: advances biological; therapies dyslipidemias; atherosclerosis; biological therapies ... See more keywords
Ocular side effects of novel anti-cancer biological therapies
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-020-80898-7
Abstract: To examine the ocular side effects of selected biological anti-cancer therapies and the ocular and systemic prognosis of patients receiving them. We retrospectively reviewed all medical records of patients who received biological anti-cancer treatment from… read more here.
Keywords: ocular side; treatment; anti cancer; biological therapies ... See more keywords
Biological therapies for eosinophilic asthma
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2018.1492540
Abstract: ABSTRACT Introduction: Severe uncontrolled asthma is by definition refractory to traditional therapies or can be controlled only with therapies that have intolerable side effects. Monoclonal antibodies that target interleukin (IL)-5/IL-5Rα, IgE, and IL-4Rα have shown… read more here.
Keywords: severe eosinophilic; therapies eosinophilic; eosinophilic asthma; clinical trials ... See more keywords
Biological therapies for myasthenia gravis
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2023.2184257
Abstract: ABSTRACT Introduction Recently, treatments for myasthenia gravis (MG) have progressed significantly. Symptoms of some patients with refractory MG are not relieved by conventional therapies, and such patients might benefit from novel biological treatments that are… read more here.
Keywords: therapies myasthenia; myasthenia gravis; biological therapies;
Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies
Sign Up to like & getrecommendations! Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy259
Abstract: Abstract We report the case of a 65-year-old patient with pseudolymphoma who developed acute toxoplasmosis following 6 cycles of rituximab and bendamustine therapy. Acute toxoplasmosis in the setting of biological response modifiers, rather than reactivation,… read more here.
Keywords: era biological; dissemination encephalitis; acute toxoplasma; toxoplasma dissemination ... See more keywords
P017 Prescription trends and reasons for discontinuation amongst at-home biological therapies
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.059
Abstract: Our unit currently follows the 2019 British Society of Rheumatology Guidelines in the prescribing and monitoring of bDMARDs which advocates 3-6 monthly monitoring blood tests in patients prescribed a biologic without a concomitant csDMARD. The… read more here.
Keywords: anti tnf; rheumatology; biological therapies; number ... See more keywords
Ocular conjunctivitis in biological therapies for atopic dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Dermatology"
DOI: 10.1111/bjd.20945
Abstract: 1 Isedeh P, Kohli I, Al-Jamal M et al. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol 2016; 174:862–8. 2 Bae-Harboe Y-SC, Graber EM.… read more here.
Keywords: conjunctivitis biological; ocular conjunctivitis; biological therapies; therapies atopic ... See more keywords
AB0453 Biological therapies retention rate in two sudamerican countries. data from biobadaguay registry
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.6109
Abstract: Background The retention rates (RR) of biological therapies (BT) have been extensively studied in European countries and the United States, but there is a lack of information about them in emerging populations. Objectives To analyse… read more here.
Keywords: biobadaguay registry; retention rate; arthritis; discontinuation ... See more keywords